Biogen Added To Alteogen’s Long List Of Partners

robot
Abstract generation in progress

Alteogen Inc. has secured a significant deal with Biogen, valued at $579 million, for SC Biologics. This agreement marks Alteogen’s second global partnership this year, further expanding its list of collaborators in the biotech sector.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin